153 related articles for article (PubMed ID: 37705061)
21.
Zhang JW; Zhang D; Yin HS; Zhang H; Hong KQ; Yuan JP; Yu BP
Gut Microbes; 2023; 15(1):2197836. PubMed ID: 37017266
[TBL] [Abstract][Full Text] [Related]
22. Downregulation of fibulin-4 inhibits autophagy and promotes the sensitivity of esophageal squamous cell carcinoma cells to apatinib by activating the Akt-mTOR signaling pathway.
Chen X; Wang J; Song L; Yu Y; Shi M; Jiang W; Liu X; He X
Thorac Cancer; 2022 Sep; 13(18):2592-2605. PubMed ID: 35950373
[TBL] [Abstract][Full Text] [Related]
23. ETV5 overexpression promotes progression of esophageal squamous cell carcinoma by upregulating SKA1 and TRPV2.
Sun MC; Fang K; Li ZX; Chu Y; Xu AP; Zhao ZY; Leng ZY; Zhang YW; Zhang ZH; Zhang L; Chen T; Xu MD
Int J Med Sci; 2022; 19(6):1072-1081. PubMed ID: 35813298
[TBL] [Abstract][Full Text] [Related]
24. P21-activated kinase 7 mediates cisplatin-resistance of esophageal squamous carcinoma cells with Aurora-A overexpression.
He S; Feng M; Liu M; Yang S; Yan S; Zhang W; Wang Z; Hu C; Xu Q; Chen L; Zhu H; Xu N
PLoS One; 2014; 9(12):e113989. PubMed ID: 25436453
[TBL] [Abstract][Full Text] [Related]
25. miR-338-5p inhibits cell proliferation, colony formation, migration and cisplatin resistance in esophageal squamous cancer cells by targeting FERMT2.
Lin WC; Chen LH; Hsieh YC; Yang PW; Lai LC; Chuang EY; Lee JM; Tsai MH
Carcinogenesis; 2019 Jul; 40(7):883-892. PubMed ID: 30576425
[TBL] [Abstract][Full Text] [Related]
26. M2 tumor-associated macrophage mediates the maintenance of stemness to promote cisplatin resistance by secreting TGF-β1 in esophageal squamous cell carcinoma.
Yang K; Xie Y; Xue L; Li F; Luo C; Liang W; Zhang H; Li Y; Ren Y; Zhao M; Wang W; Liu J; Shen X; Zhou W; Fei J; Chen W; Gu W; Wang L; Li F; Hu J
J Transl Med; 2023 Jan; 21(1):26. PubMed ID: 36641471
[TBL] [Abstract][Full Text] [Related]
27. Hypomethylation-Linked Activation of PLCE1 Impedes Autophagy and Promotes Tumorigenesis through MDM2-Mediated Ubiquitination and Destabilization of p53.
Chen Y; Xin H; Peng H; Shi Q; Li M; Yu J; Tian Y; Han X; Chen X; Zheng Y; Li J; Yang Z; Yang L; Hu J; Huang X; Liu Z; Huang X; Zhou H; Cui X; Li F
Cancer Res; 2020 Jun; 80(11):2175-2189. PubMed ID: 32066565
[TBL] [Abstract][Full Text] [Related]
28. Downregulation of Claudin5 promotes malignant progression and radioresistance through Beclin1-mediated autophagy in esophageal squamous cell carcinoma.
Huang S; Zhang J; Li Y; Xu Y; Jia H; An L; Wang X; Yang Y
J Transl Med; 2023 Jun; 21(1):379. PubMed ID: 37303041
[TBL] [Abstract][Full Text] [Related]
29. The HSP90 inhibitor 17-N-allylamino-17-demethoxy geldanamycin (17-AAG) synergizes with cisplatin and induces apoptosis in cisplatin-resistant esophageal squamous cell carcinoma cell lines via the Akt/XIAP pathway.
Ui T; Morishima K; Saito S; Sakuma Y; Fujii H; Hosoya Y; Ishikawa S; Aburatani H; Fukayama M; Niki T; Yasuda Y
Oncol Rep; 2014 Feb; 31(2):619-24. PubMed ID: 24317439
[TBL] [Abstract][Full Text] [Related]
30. Krüppel-Like Factor 4 Enhances Sensitivity of Cisplatin to Esophageal Squamous Cell Carcinoma (ESCC) Cells.
Chen C; Ma Z; Zhang H; Liu X; Yu Z
Med Sci Monit; 2017 Jul; 23():3353-3359. PubMed ID: 28694421
[TBL] [Abstract][Full Text] [Related]
31. TNF‑α‑mediated upregulation of SOD‑2 contributes to cell proliferation and cisplatin resistance in esophageal squamous cell carcinoma.
Zuo J; Zhao M; Liu B; Han X; Li Y; Wang W; Zhang Q; Lv P; Xing L; Shen H; Zhang X
Oncol Rep; 2019 Oct; 42(4):1497-1506. PubMed ID: 31364751
[TBL] [Abstract][Full Text] [Related]
32. CMTM6 drives cisplatin resistance by regulating Wnt signaling through the ENO-1/AKT/GSK3β axis.
Mohapatra P; Shriwas O; Mohanty S; Ghosh A; Smita S; Kaushik SR; Arya R; Rath R; Das Majumdar SK; Muduly DK; Raghav SK; Nanda RK; Dash R
JCI Insight; 2021 Feb; 6(4):. PubMed ID: 33434185
[TBL] [Abstract][Full Text] [Related]
33. Upregulation of KCNMA1 facilitates the reversal effect of verapamil on the chemoresistance to cisplatin of esophageal squamous cell carcinoma cells.
Ge N; Yang GS; Zhang TY; Chang N; Kang YH; Zhou Q; Fan PS
Eur Rev Med Pharmacol Sci; 2021 Feb; 25(4):1869-1880. PubMed ID: 33660797
[TBL] [Abstract][Full Text] [Related]
34. BTN3A1 promotes tumor progression and radiation resistance in esophageal squamous cell carcinoma by regulating ULK1-mediated autophagy.
Yang W; Cheng B; Chen P; Sun X; Wen Z; Cheng Y
Cell Death Dis; 2022 Nov; 13(11):984. PubMed ID: 36418890
[TBL] [Abstract][Full Text] [Related]
35. RUNX3 reverses cisplatin resistance in esophageal squamous cell carcinoma via suppression of the protein kinase B pathway.
Li DJ; Shi M; Wang Z
Thorac Cancer; 2016 Sep; 7(5):570-580. PubMed ID: 27766776
[TBL] [Abstract][Full Text] [Related]
36. PDK1 regulates the progression of esophageal squamous cell carcinoma through metabolic reprogramming.
Ma Y; Zhang X; Han X; Hao Z; Ji R; Li J; Guo W; Zhang Y; Guan F; Ma S
Mol Carcinog; 2023 Jun; 62(6):866-881. PubMed ID: 36988347
[TBL] [Abstract][Full Text] [Related]
37. CCT4 knockdown enhances the sensitivity of cisplatin by inhibiting glycolysis in human esophageal squamous cell carcinomas.
Fang J; Ma Y; Li Y; Li J; Zhang X; Han X; Ma S; Guan F
Mol Carcinog; 2022 Nov; 61(11):1043-1055. PubMed ID: 36102200
[TBL] [Abstract][Full Text] [Related]
38. SRPX2 knockdown inhibits cell proliferation and metastasis and promotes chemosensitivity in esophageal squamous cell carcinoma.
He F; Wang H; Li Y; Liu W; Gao X; Chen D; Wang Q; Shi G
Biomed Pharmacother; 2019 Jan; 109():671-678. PubMed ID: 30551519
[TBL] [Abstract][Full Text] [Related]
39. MicroRNA-338-5p reverses chemoresistance and inhibits invasion of esophageal squamous cell carcinoma cells by targeting Id-1.
Han L; Cui D; Li B; Xu WW; Lam AKY; Chan KT; Zhu Y; Lee NPY; Law SYK; Guan XY; Qin YR; Chan KW; Ma S; Tsao SW; Cheung ALM
Cancer Sci; 2019 Dec; 110(12):3677-3688. PubMed ID: 31646712
[TBL] [Abstract][Full Text] [Related]
40. Hsa_circ_0007142 contributes to cisplatin resistance in esophageal squamous cell carcinoma via miR-494-3p/LASP1 axis.
Chang N; Ge N; Zhao Y; Yang L; Qin W; Cui Y
J Clin Lab Anal; 2022 May; 36(5):e24304. PubMed ID: 35312115
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
